Background Countries with similar health systems but different medicines policies might
result in substantial medicines usage differences and resultant outcomes. The literature is …

Introduction: Our objective was to analyze and compare systematically and structurally
reimbursement systems in Poland and other countries. Methods: The systems were selected …

Economic theory assumes accurate price information to be readily available in markets. In
real markets, however, actual price information can be private and confidential, forcing …

Medicine price directly affects affordability and access to medicines particularly in countries
where a major portion of pharmaceutical spending is through out-of-pocket payment, such …

Objectives The cost-effectiveness of low-dose computed tomography (LDCT) screening for
lung cancer is uncertain. This study estimated the health gains, costs (net health system, and …

Objectives The cost-effectiveness of low-dose computed tomography (LDCT) screening for
lung cancer is uncertain. This study estimated the health gains, costs (net health system, and …

Regulatory evaluation and approval of pharmaceuticals is required if new medicines are to
be permitted entry onto the market in most developed countries. Certain state bodies also …

Supply chain information visibility (SCIV) has been largely recognized as a key issue in
pharmaceutical supply chain management. In recent years, there has been growing concern …

We read Taylor and Wonder, s analysis of newly publicly funded medicines in New Zealand
and Australia with great interest. 1 Their results concur with the small but growing body of …

Objetivo: Análise das práticas regulatórias e funcionamento dos sistemas de saúde em
diferentes países, com foco principal na regulação de planos de saúde vinculados ao setor …